Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia

References

• Britt NS, Ritchie DJ, Kollef MH, et al. Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: shifting burden of disease? Am J Infect Control. 2018;46(10):1092–1096. doi:10.1016/j.ajic.2018.03.01329706365
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011. doi:10.1086/591861.18947320
   PubMed Web of Science ®Google Scholar
• Livorsi DJ, Chorazy ML, Schweizer ML, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control. 2018;7(1):55. doi:10.1186/s13756-018-0346-9.29719718
   PubMed Web of Science ®Google Scholar
• Centers of Korea disease control. Infectious disease portal Secondary Infectious disease portal 2020 http://www.cdc.go.kr/npt/biz/npp/ist/simple/simplePdStatsMain.do. Accessed 928, 2020.
   Google Scholar
• Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect. 2015;21(1):30–34. doi:10.1016/j.cmi.2014.08.001.25636924
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi:10.1016/S1473-3099(09)70054-4.19324295
   PubMed Web of Science ®Google Scholar
• Prematunge C, MacDougall C, Johnstone J, et al. VRE and VSE bacteremia outcomes in the era of effective VRE therapy: A systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):26–35. doi:10.1017/ice.2015.228.26434609
   PubMed Web of Science ®Google Scholar
• McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann A-C, Lazzeri C. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017;12(10):e0186195. doi:10.1371/journal.pone.018619529023567
   PubMed Web of Science ®Google Scholar
• World Health Organization. Expert Committee on the International Classification of Diseases M, World Health Organization. Development of E, Health Statistical Services U. Expert Committee on the International Classification of Diseases, 10th Revision, Second Meeting, Geneva, November 23–27 1987 [Report]. Geneva, Switzerland: World Health Organization; 1987.
   Google Scholar
• Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing. 30 ed. Vol. 296 2020.
   Google Scholar
• Poon LM, Jin J, Chee YL, et al. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Singapore Med J. 2012;53(11):720–725.23192498
   PubMed Web of Science ®Google Scholar
• Oliveira PMN, Buonora SN, Souza CLP, et al. Surveillance of multidrug-resistant bacteria in pediatric and neonatal intensive care units in Rio de Janeiro State, Brazil. Rev Soc Bras Med Trop. 2019;52:e20190205. doi:10.1590/0037-8682-0205-2019.31508783
   PubMed Web of Science ®Google Scholar
• Han SH, Chin BS, Lee HS, et al. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect. 2009;58(3):182–190. doi:10.1016/j.jinf.2009.01.013.19233476
   PubMed Web of Science ®Google Scholar
• Hefazi M, Damlaj M, Alkhateeb HB, et al. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Transpl Infect Dis off J Transplant Soc. 2016;18(6):913–920. doi:10.1111/tid.12612.
   Web of Science ®Google Scholar
• Hayakawa K, Marchaim D, Martin ET, et al. Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia. Antimicrob Agents Chemother. 2012;56(5):2452–2458. doi:10.1128/AAC.06299-11.22354290
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Q, Yin Y, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob Agents Chemother. 2018;62:2. doi:10.1128/AAC.01882-17.
   Web of Science ®Google Scholar
• Ghafur A, Devarajan V, Raja T, et al. Monotherapy versus combination therapy against carbapenem-resistant Gram-negative bacteria: A retrospective observational study. Indian Journal of Cancer. 2016;53(4):592–594. doi:10.4103/0019-509X.204767.28485360
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Chen L, Patel G, et al. Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States. Antimicrob Agents Chemother. 2017;61(4):4. doi:10.1128/AAC.02349-16.
   Web of Science ®Google Scholar
• Li C, Li Y, Zhao Z, Liu Q, Li B. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital. J Infect Public Health. 2019;12(1):26–31. doi:10.1016/j.jiph.2018.08.002.30145151
   PubMed Web of Science ®Google Scholar
• Cai Y, Seah CL, Leck H, et al. Rapid antibiotic combination testing for carbapenem-resistant Gram-negative bacteria within six hours using ATP bioluminescence. Antimicrob Agents Chemother. 2018;62(9):e00183–18. doi:10.1128/AAC.00183-18.29967021
   PubMed Web of Science ®Google Scholar
• Henderson H, Luterbach CL, Cober E, et al. The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections. Clin Infect Dis off Publ Infect Dis Soc Am. 2020;70(9):1826–1833. doi:10.1093/cid/ciz528.
   Web of Science ®Google Scholar
• Shi H, Kang C-I, Cho SY, Huh K, Chung DR, Peck KR. Follow-up blood cultures add little value in the management of bacteremic urinary tract infections. Eur J Clin Microbiol Infect Dis. 2019;38(4):695–702. doi:10.1007/s10096-019-03484-4.30689071
   PubMed Web of Science ®Google Scholar
• Canzoneri CN, Akhavan BJ, Tosur Z, Andrade PEA, Aisenberg GM. Follow-up blood cultures in Gram-negative bacteremia: are they needed? Clin Infect Dis. 2017;65(11):1776–1779. doi:10.1093/cid/cix648.29020307
   PubMed Web of Science ®Google Scholar
• Pal A, Tripathi A. 4-Chloromercuribenzoic acid enhances carbapenem sensitivity among pathogenic Gram negative bacteria by altering bla, adeB and ompC expression. J Infect Public Health. 2020;13(5):806–814. doi:10.1016/j.jiph.2019.11.008.31836318
   PubMed Web of Science ®Google Scholar
• Rodríguez EA, Garzón LM, Gómez ID, Jiménez JN. Multidrug resistance and diversity of resistance profiles in carbapenem-resistant Gram-negative bacilli throughout a wastewater treatment plant in Colombia. J Glob Antimicrob Resist. 2020;22:358–366. doi:10.1016/j.jgar.2020.02.033.32200126
   PubMed Web of Science ®Google Scholar
• Papst L, Beović B, Pulcini C, et al. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect. 2018;24(10):1070–1076. doi:10.1016/j.cmi.2018.01.015.29410094
   PubMed Web of Science ®Google Scholar